KaloBios (KBIOQ) Completes Chapter 11 Bankruptcy; Acquires Benznidazole Development Rights
Tweet Send to a Friend
KaloBios Pharmaceuticals, Inc. (OTC: KBIOQ) announced that it has emerged from Chapter 11 bankruptcy and has also acquired the rights ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
